These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25511871)

  • 21. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of therapeutic vaccination for the treatment of chronic hepatitis B virus infection.
    Lee YB; Lee JH; Kim YJ; Yoon JH; Lee HS
    J Med Virol; 2015 Apr; 87(4):575-82. PubMed ID: 25611586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcoming immune tolerance in chronic hepatitis B by therapeutic vaccination.
    Dembek C; Protzer U; Roggendorf M
    Curr Opin Virol; 2018 Jun; 30():58-67. PubMed ID: 29751272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral hepatitis. HBV cure--can we pin our hopes on immunotherapy?
    Yang HC; Kao JH
    Nat Rev Gastroenterol Hepatol; 2015 Mar; 12(3):129-31. PubMed ID: 25623202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
    Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
    Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic vaccination in chronic hepatitis B virus carriers.
    Pol S; Michel ML
    Expert Rev Vaccines; 2006 Oct; 5(5):707-16. PubMed ID: 17181443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects and progress of DNA vaccines for treating hepatitis B.
    Chen M; Jagya N; Bansal R; Frelin L; Sällberg M
    Expert Rev Vaccines; 2016 May; 15(5):629-40. PubMed ID: 26652035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.
    Yoon SK; Seo YB; Im SJ; Bae SH; Song MJ; You CR; Jang JW; Yang SH; Suh YS; Song JS; Kim BM; Kim CY; Jeong SH; Sung YC
    Liver Int; 2015 Mar; 35(3):805-15. PubMed ID: 24620920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus: from diagnosis to treatment.
    Dény P; Zoulim F
    Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The woodchuck: a model for therapeutic vaccination against hepadnaviral infection.
    Roggendorf M; Yang D; Lu M
    Pathol Biol (Paris); 2010 Aug; 58(4):308-14. PubMed ID: 20646874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulatory therapy for chronic hepatitis B virus infection.
    Sprengers D; Janssen HL
    Fundam Clin Pharmacol; 2005 Feb; 19(1):17-26. PubMed ID: 15660957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological cure of HBV infection.
    Lang J; Neumann-Haefelin C; Thimme R
    Hepatol Int; 2019 Mar; 13(2):113-124. PubMed ID: 30600480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
    Koh S; Bertoletti A
    Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp.
    Farag MM; Tedjokusumo R; Flechtenmacher C; Asen T; Stremmel W; Müller M; Protzer U; Weigand K
    Vaccine; 2012 Sep; 30(42):6034-9. PubMed ID: 22867720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse models for therapeutic vaccination against hepatitis B virus.
    Dembek C; Protzer U
    Med Microbiol Immunol; 2015 Feb; 204(1):95-102. PubMed ID: 25523197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.
    Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Bréchot C; Michel ML
    Hepatology; 2004 Oct; 40(4):874-82. PubMed ID: 15382173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence.
    Takaki A; Yasunaka T; Yagi T
    Int J Mol Sci; 2015 Jul; 16(8):17494-513. PubMed ID: 26263973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future prevention and treatment of chronic hepatitis B infection.
    Seto WK; Fung J; Yuen MF; Lai CL
    J Clin Gastroenterol; 2012 Oct; 46(9):725-34. PubMed ID: 22914347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.